◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › F › FDA

Fidia S.p.A. (FDA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Industrials · Specialty Industrial Machinery · DATA UPDATED 2026-10-03

Fidia S.p.A. (FDA) operates in the Specialty Industrial Machinery industry and is headquartered in Turin, Italy with about 146 employees. Its market capitalization is roughly €14 million. In the fiscal year ended 2025-12-31, FDA reported €31M in revenue and €1M in net income.

Fidia S.p.A., together with its subsidiaries, production and sale of numerical controls and software, high-speed milling systems and after-sales technical assistance.

Interactive charts & full statements → Open the FDA valuation workbench →

FDA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€31M€18M€29M€25M—
Gross Profit€20M€14M€20M€15M—
Operating Income (EBIT)(€1M)(€6M)(€1M)(€4M)—
Net Income€1M(€9M)(€1M)€6M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FDA Free Cash Flow History

FDA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€26M€28M€32M€34M—
Total Liabilities€18M€25M€29M€28M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FDA viewer.

Other Companies in Specialty Industrial Machinery

← FCXGAll “F” companiesFDAT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.